Production of Sudocrem the medicated healing cream is to move from Baldoyle in Dublin to Bulgaria.
Invented in 1931 by Cabra pharmacist, Professor Thomas Smith, Sudocrem is an antiseptic healing cream used to treat numerous skin conditions, including nappy rash, eczema, acne, minor burns and surface wounds. Available in over 50 countries with more than 34.4 million pots sold worldwide every year. Sudocrem has been produced in Baldoyle, County Dublin, since the 1940s.
Pharmaceutical company Teva is to close the Sudocrem manufacturing plant in Baldoyle, with the loss of 110 jobs. The Dublin factory is expected to begin winding down operations and close its manufacturing plant at the end of 2022. In 2023, when production moves to Troyan in Bulgaria, Sudocrem will no longer be an Irish product.
Paul Williams theTeva senior director of corporate affairs for the UK and Ireland , explains the company is moving production to Bulgaria because the Baldoyle site does not allow for expansion.
Baldoyle can't grow in the way that Sudocrem is growing.
For staff in Baldoyle, many of whom are local to the area, the news came as a shock and a disappointment.
The company's been here for 40 years and it's a sad day.
Tánaiste and Minister for Employment Leo Varadkar assured the workers that the government will make all necessary State assistance available to them.
Despite the decision, Teva says it remains committed to the Irish market and will continue to have a presence in Ireland with its respiratory manufacturing plant in Waterford.
An RTÉ News report broadcast on 7 May 2021. The reporter is Will Goodbody.
